Analysis of the clinical application and treatment effects of Ultra-Pulse Shockwave technology in facial rejuvenation
摘要
Facial aging involves structural changes in the skin, subcutaneous tissues, and skeletal framework. Ultra-Pulse Shockwave (UPSW) therapy, a non-thermal, high-frequency shockwave technology, has emerged as a promising, non-invasive option for facial rejuvenation. This study evaluates the efficacy and safety of UPSW in improving skin texture, reducing subcutaneous fat, and enhancing skin tightness. A clinical study was conducted with 20 participants (ages 25–60) undergoing three UPSW treatment sessions over six weeks. Objective assessments included standardized photography, VISIA skin analysis, and Paragon XHD ultrasound imaging to document and analyze treatment effects. Subjective evaluations were performed using the Global Aesthetic Improvement Scale (GAIS) to measure aesthetic outcomes and the Visual Analog Scale (VAS) to assess pain levels experienced during and after treatment. UPSW therapy significantly improved skin texture (p = 0.010) and showed promising effects on subcutaneous fat reduction and skin tightness. Wrinkles (p = 0.069) and pores (p = 0.232) did not reach statistical significance. Adverse effects, including transient erythema and mild edema, were minor and self-limiting. The mean VAS pain score was 2.8, indicating high tolerability. Ultra-Pulse Shockwave (UPSW) therapy demonstrated both safety and efficacy as a non-invasive treatment for facial rejuvenation. The findings indicate that UPSW significantly enhances skin texture while exerting positive effects on skin tightening and subcutaneous fat reduction. Despite the limitations of a small sample size, limited treatment sessions, and a short follow-up period, this study highlights UPSW’s potential as a valuable addition to aesthetic medicine. Further research involving larger cohorts, more frequent treatments, and extended follow-up durations is recommended to optimize treatment protocols and comprehensively evaluate its long-term benefits.